Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NRx Pharmaceuticals 2021 financial update, Aviptadil Patent, Zyesami, Relief Therapeutics, BriLife August 17 2021
FROM US Patent and Trademark Office
https://patents.google.com/patent/US8263571B2/en?oq=8263571
You are missing one important point... With all those side effects... they can sell you another pill to help rid you of all of that... But that too will have side effects... Never ending... lol
From
Inelgr Friday, 07/23/21 03:11:34 PM
Quote:
reverse splits are usually not a good thing. just saying, Well in most cases they are not a good thing...
True, but as you allude to, 100% of RS are not bad.
==============================================================
I have seen RS's that were both good and bad. If the company is in trouble... then I would worry.. Otherwise, a RS can get the SP up to a level where institutional investors can invest. They usually do not invest in stocks below a buck...
Thanks elllk! Very interesting! B
Watching the PPS or a rapid large purchase of shares? I guess you can have large unusual purchases that don't really fast high spike the SP.. And it all depends on how tight lipped the FDC people are! You can go to jail for lesser things.. Ask Martha! But it can also be like a large flock of birds.. one bird see just one bird panic and take fast flight and the rest follow in mass!
Thanks Bill....
No... I am serious... I just don't know how a link to the FDC would be connected unless there is a bribe a payoff or some inside political pressure... and I know Trump did pressure government agencies as well.. Not trying to be political... both parties have been guilty for sure! But I think Big Pharma would need some sort of link or help to influence the FDA.
I know with the military... SOME generals and or commanders would favor certain military companies because they knew that as soon as they got out they would almost be guaranteed to get jobs with them worth millions. I know.. I worked and retired from two military aircraft companies... some parts of them were run by X-High ranking influential military who still had a lot of connections and influence in DC... That helps tremendously with future contracts! Perhaps the FDA people in power may want the same links to being hired with Big Pharma..
That may be a link... but how do you prove it? Not easy!
You stated: "Zyesami is battling Big Pharma not vaccinations."
OK... So then does that mean that "Big Pharma" has influence over the FDA and obtaining an EUA? Is "Big Pharma" influencing our government?
How did you determine this? A serious question worth looking into. Seems that would be sort of illegal!
Most government agencies are so thick with red tape and slow processes that they move at a snail's pace. Job security and no incentive to move fast and people in authority who love to use that authority in their own sweet time. For example, I have sat in the CA DMV for over three hours waiting... If the DMV relied on a capitalistic system of having to make a profit under competition, I would have been in and out of there in 15 minutes!
But.. Like him or hate him, Trump was a very aggressive individual when it came to getting his way. He really put a lot of pressure on the CDC and the FDA. There was a reason that we have vaccines years ahead of what it would have taken. But... so now we are back to normal and no one in the Biden admin will dare push the FDA for a rapid response. In fact, they really want people to take the vaccine and anything that may prevent people from doing so will be shunned.
We may see approval in the rest of the World before we see it here in the US. I hope not, but that may happen! Whatever it takes...
Not trying to bring up politics here, but just want to point out that there is a distinct difference in styles between the last admin and the current one. Trump was not a shy individual when it came to confrontation and neither were his appointees. I can only imagine the pressure he put on the drug companies and he also put a huge carrot in front of their faces to get the vaccine done and approved in record time. He also influenced speedy decision making for therapeutics.
It just seems that now, the pressure has backed off. A lot of these government agencies in the past liked to pad the time it took and also add red tape to the process all for job security... not to mention the influence on their own self importance and authority to do things in their own sweet time.
The other factor is the vaccination % rate that Biden promised by the 4th of July. That ain't going to happen now so they are saying. So a therapeutic such as ZYESAMI may inhibit some people from taking the vaccine because they feel there are other options to survive. They may not have wanted to advertise other options.
And when it comes to politics, our politicians will do most anything to influence the masses so they and their party can stay in power!
There is rumor that in particular the WHO and the FDA have been downplaying the positive effects of drugs such as Ivermectin and hydrochlorquin for the main reason that they were worried those options would steer people away from actually taking the covid vaccine! If people knew they had other options I am sure it would have stopped a lot of folks from taking the vaccine. It could have also helped to open up society and the economy as well. An investigation should follow.
Apparently a just released report this last Friday states that early use of Ivermectin reduces death by 74%. People who talked about these drugs on social media last year had their words banned or they were banned from Youtube, FB or Twitter. Fauci was working in concert (proven in discovered emailings) with FB Zuckerberg to control information regarding these drugs. Fauci was undermining freedom of speech and perhaps prevented thousands of people learning the truth and thus saving lives and when did Zuckerberg receive his medical degree!
My concern is that perhaps our application for an emergency use approval of ZYESAMI is possible being held up for that same reason. Manipulation!
Great show on this morning on FOX by Maria Bartiromo on this very subject. Worth watching if you can watch the later repeated broadcast. But they also said that NOW Fauci is looking for preventative drugs... Covering his ass??
Article: Don’t mention Ivermectin; it’ll upset the vaccine rollout
12th May 2021 by Editor
https://www.biznews.com/thought-leaders/2021/05/12/mailbox-ivermectin
(This is a paragraph from an article worth reading:)
"In January this year, the several months long, Ivermectin research, meta-analysis of Randomised Control Trials (RCT), commissioned by WHO was released. The paper showed that Ivermectin reduces death by 74% and is 85% effective as prophylaxis. The trial leader, Dr Andrew Hill, was on Zoom meetings saying that governments should secure their source before demand outstrips supply and that it would be immoral, not to roll it out. The same month, two other independent, unsponsored meta-analysis confirmed a similar range of effectiveness at various stages of the disease. While effective at all stages of the disease, Ivermectin is most effective as a prophylaxis and about 80% in early treatment, depending on dose used."
So has the FDA been dragging their feet with us on purpose???
NRx Pharmaceuticals to Lead Development of COVID-19 Medicines and Vaccines in Central Europe and the Caucasus Region in Collaboration with the Lugar Institute and Cromos Pharma
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-to-lead-development-of-covid-19-medicines-and-vaccines-in-central-europe-and-the-caucasus-region-in-collaboration-with-the-lugar-institute-and-cromos-pharma-301299950.html
Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA
25 May 21
https://finance.yahoo.com/news/acer-therapeutics-plans-nda-submission-123000292.html
"NEWTON, Mass. and GENEVA, Switzerland, May 25, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER)(“Acer”), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, and RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF)(“Relief”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced the outcome of Acer’s pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) for ACER-001 for the treatment of Urea Cycle Disorders (UCDs). ACER-001 is a proprietary immediate release multi-particulate powder formulation of sodium phenylbutyrate (NaPB) with a taste-masked coating. ACER-001 is being developed in collaboration with Relief.
The purpose of the pre-NDA meeting was to discuss the content of Acer’s planned NDA submission. Based on FDA feedback, the Companies believe the proposed data package will be sufficient to support an NDA submission under the Section 505(b)(2) regulatory pathway of ACER-001 for the treatment of patients with UCDs. Following NDA submission and FDA determination of acceptance for filing, the FDA will conduct a substantive review before deciding upon the action on the application.
“We are pleased with the outcome of our recent pre-NDA meeting with FDA, supporting our belief that the studies and data we intend to include in our planned NDA for ACER-001 should be sufficient for NDA submission,” said Chris Schelling, CEO and Founder of Acer. “We remain on track to complete the NDA submission in Q3 2021, provided that we obtain agreement with the FDA on our initial pediatric study plan (iPSP).”
Jack Weinstein, CFO and Treasurer of Relief Therapeutics, added: “The outcome of the pre-NDA meeting with the FDA is highly encouraging and marks an important milestone in support of the development and potential commercialization of ACER-001 worldwide. We are pleased with the progress of the ACER-001 program and look forward to working with the Acer team to potentially bring to market an alternative to existing NaPB-based treatments.”
Thank you for that! Indeed there is a huge amount of data to sort and submit. Dr J should utilize the ignore option like so many of us have. Someone here has been so accusing and insulting against him and others. I am surprised that that doesn't break any rules here. Certainly there are civil laws against defamation of character.
Thanks for that info...
I do not see that they were halted.. Not questioning you.. I just must be missing something...
Thanks for posting that... They are giving a submission deadline of July 13, 2021... Then it will take a while to evaluate the data. Tells me that they will not be deciding on the emergency use issue until at least Aug or Sep at the earliest. I don't think anyone in this current admin is putting any pressure or pushing anyone to get off their butts. Back to a slow roll government pace.
Yes...but having bad laser units provided to them did not help. As for the rest... fraud etc., hopefully we will see the total truth through the courts.
Thanks for that info!
Interesting that Mynaric is supporting Spacelink with laser communications units when they were the same ones working with Airborne Wireless Network in 2017... but those units had issues.
Mynaric delivers Laser Terminal flight units for upcoming Flight Test for Airborne Wireless Network
https://mynaric.com › news › mynaric-delivers-laser-termi...
Dec 6, 2017
==================================================================
SpaceLink and Mynaric join forces; sign term sheet on sale of laser communication products and expansion of product portfolio
Press Release From: Mynaric
Posted: Wednesday, May 12, 2021
http://spaceref.com/news/viewpr.html?pid=57415
Mynaric and SpaceLink today agreed on the framework of a partnership to expand Mynaric’s laser communication product portfolio for use in SpaceLink’s data relay network. The strategic relationship will help drive forward the SpaceLink satellite relay service, which provides secure, continuous, high-capacity communications between low Earth orbit (LEO) spacecraft and the ground.
The companies will work together to expand Mynaric’s product portfolio with an optical inter-satellite link (OISL) terminal for satellites in medium Earth orbit (MEO), where the SpaceLink constellation will operate. The new terminal will also be compatible with the Space Development Agency (SDA) Transport Layer.
Mynaric will supply more than 40 OISL terminals as part of the plan outlined in a term sheet, which includes units of the new, advanced product for satellites in MEO as well as units of Mynaric’s CONDOR terminals for SpaceLink LEO customers. SpaceLink and Mynaric have also agreed to an option that would increase the number of terminals delivered upon SpaceLink’s expansion of its MEO constellation.
Laser communication technology is critical for SpaceLink to build the communication superhighways for the new space economy. Mynaric’s product portfolio is a natural choice as it meets SpaceLink’s programmatic requirements, provides high performance, and is fully compliant with the OISL Standard driven by the SDA. This is a major benefit that allows SpaceLink to serve the largest possible range of commercial and government customers.
SpaceLink is building its high-capacity data relay network to meet pent-up demand for continuous, fast, and secure access to the growing amount of data available from space. The Always in Sight™ constellation helps satellite operators maximize the value of on-orbit assets with near real time transmission of user data to the ground for immediate access via the Internet, private cloud, or other secure delivery. Mynaric was selected as a supplier to support SpaceLink’s mission given its industrialized approach towards the production of advanced laser communication products.
“Our work with Mynaric to implement advanced OISL capability into the SpaceLink constellation will ensure performance and interoperability. Mynaric has exceptional expertise to advance a new generation of OISLs that address our requirements and our mission to speed massive amounts of data to users no matter where they are located on Earth. Together with Mynaric, SpaceLink will enable our customers to take a quantum leap in delivering data that saves lives and advances humanity to a new age of space commerce, exploration, environmental awareness, and security.”
David Bettinger, CEO SpaceLink
“This partnership closes on the largest direct acquisition of laser communication products by a commercial entity to date to our knowledge and touches multiple aspects that are at the core of our strategy of industrializing laser communications: Signing a lead customer to expand our product portfolio with a product suitable for MEO satellites while gaining a channel partner for our LEO terminals compliant with the SDA Standard. We are excited to partner with SpaceLink to supply products to and support their mission to enable secure, high-capacity data access in space.”
Bulent Altan, CEO Mynaric
About Spacelink
SpaceLink is building an information superhighway for the space economy that will help advance humanity to a new age of space commerce, exploration, environmental awareness, and security. The Always in Sight™ data relay system provides global coverage to empower space system operators to maximize use of their assets. SpaceLink Corporation is headquartered in the Washington DC area and has offices in Silicon Valley, California. It is a wholly owned subsidiary of Electro Optic Systems Holdings Limited, a public company traded on the Australian stock exchange.
About Mynaric
Mynaric (Frankfurt Stock Exchange: M0Y, ISIN: DE000A0JCY11) produces the optical fiber for the skies and, as a pioneer of laser communication, enables extremely fast and secure wireless data transmission between aircraft, drones and satellites. Globally, the need for fast and ubiquitous network connectivity is advancing inexorably. Data networks such as the internet are now largely based on infrastructure on the ground which cannot be expanded arbitrarily for legal, economic or logistical reasons. The future, therefore, calls for an expansion of the existing network infrastructure into air and space. Mynaric provides laser communication products to establish the necessary data highways for telecommunication constellations in air and space.
Interesting that Mynaric is supporting Spacelink with laser communications units when they were the same ones working with Airborne Wireless Network in 2017... but those units had issues.
Mynaric delivers Laser Terminal flight units for upcoming Flight Test for Airborne Wireless Network
https://mynaric.com › news › mynaric-delivers-laser-termi...
Dec 6, 2017
SpaceLink and Mynaric join forces; sign term sheet on sale of laser communication products and expansion of product portfolio
Press Release From: Mynaric
Posted: Wednesday, May 12, 2021
http://spaceref.com/news/viewpr.html?pid=57415
Mynaric and SpaceLink today agreed on the framework of a partnership to expand Mynaric’s laser communication product portfolio for use in SpaceLink’s data relay network. The strategic relationship will help drive forward the SpaceLink satellite relay service, which provides secure, continuous, high-capacity communications between low Earth orbit (LEO) spacecraft and the ground.
The companies will work together to expand Mynaric’s product portfolio with an optical inter-satellite link (OISL) terminal for satellites in medium Earth orbit (MEO), where the SpaceLink constellation will operate. The new terminal will also be compatible with the Space Development Agency (SDA) Transport Layer.
Mynaric will supply more than 40 OISL terminals as part of the plan outlined in a term sheet, which includes units of the new, advanced product for satellites in MEO as well as units of Mynaric’s CONDOR terminals for SpaceLink LEO customers. SpaceLink and Mynaric have also agreed to an option that would increase the number of terminals delivered upon SpaceLink’s expansion of its MEO constellation.
Laser communication technology is critical for SpaceLink to build the communication superhighways for the new space economy. Mynaric’s product portfolio is a natural choice as it meets SpaceLink’s programmatic requirements, provides high performance, and is fully compliant with the OISL Standard driven by the SDA. This is a major benefit that allows SpaceLink to serve the largest possible range of commercial and government customers.
SpaceLink is building its high-capacity data relay network to meet pent-up demand for continuous, fast, and secure access to the growing amount of data available from space. The Always in Sight™ constellation helps satellite operators maximize the value of on-orbit assets with near real time transmission of user data to the ground for immediate access via the Internet, private cloud, or other secure delivery. Mynaric was selected as a supplier to support SpaceLink’s mission given its industrialized approach towards the production of advanced laser communication products.
“Our work with Mynaric to implement advanced OISL capability into the SpaceLink constellation will ensure performance and interoperability. Mynaric has exceptional expertise to advance a new generation of OISLs that address our requirements and our mission to speed massive amounts of data to users no matter where they are located on Earth. Together with Mynaric, SpaceLink will enable our customers to take a quantum leap in delivering data that saves lives and advances humanity to a new age of space commerce, exploration, environmental awareness, and security.”
David Bettinger, CEO SpaceLink
“This partnership closes on the largest direct acquisition of laser communication products by a commercial entity to date to our knowledge and touches multiple aspects that are at the core of our strategy of industrializing laser communications: Signing a lead customer to expand our product portfolio with a product suitable for MEO satellites while gaining a channel partner for our LEO terminals compliant with the SDA Standard. We are excited to partner with SpaceLink to supply products to and support their mission to enable secure, high-capacity data access in space.”
Bulent Altan, CEO Mynaric
About Spacelink
SpaceLink is building an information superhighway for the space economy that will help advance humanity to a new age of space commerce, exploration, environmental awareness, and security. The Always in Sight™ data relay system provides global coverage to empower space system operators to maximize use of their assets. SpaceLink Corporation is headquartered in the Washington DC area and has offices in Silicon Valley, California. It is a wholly owned subsidiary of Electro Optic Systems Holdings Limited, a public company traded on the Australian stock exchange.
About Mynaric
Mynaric (Frankfurt Stock Exchange: M0Y, ISIN: DE000A0JCY11) produces the optical fiber for the skies and, as a pioneer of laser communication, enables extremely fast and secure wireless data transmission between aircraft, drones and satellites. Globally, the need for fast and ubiquitous network connectivity is advancing inexorably. Data networks such as the internet are now largely based on infrastructure on the ground which cannot be expanded arbitrarily for legal, economic or logistical reasons. The future, therefore, calls for an expansion of the existing network infrastructure into air and space. Mynaric provides laser communication products to establish the necessary data highways for telecommunication constellations in air and space.
Jack.. I am not being paid for posting anything. LOL I simply posted the SEC statement regarding fraud and ABWN.. I did not write that information. It came from the SEC direct. I left a link. Take that info for what it is worth.
My speculation on recovering any funds that were taken by fraudulent individuals who manipulated this stock is just that.. speculation.
Have a good day....
Recovering Funds
https://www.investor.gov/introduction-investing/investing-basics/glossary/recovering-funds
Investors who are victims of securities law violations may be eligible to receive money recovered from fraudsters. Sometimes a successful SEC enforcement action results in recovered funds being distributed to victims.
Processes that may help victims recover money include: fair funds and disgorgement funds; receiverships; brokerage account customer protections; corporate bankruptcy proceedings; and private class action lawsuits.
Not all victims are able to recover money. Victims who do recover money may receive substantially less than their losses and the process for distributing the money may take a long time.
If those assets are still within reach.. Perhaps a class action recovery of more pennies? Purely speculation on my part... But enough to pop the SP up a couple cents? Hummmm....
From SEC
https://www.lexology.com/library/detail.aspx?g=9c36e746-e20a-48c0-a644-87cfdcc4fe7a
Manipulation: SEC v. Airborne Wireless Network, Civil Action No. 1:21-cv-01772 (S.D.N.Y. Filed March 2, 2021) is an action which names as defendants the company, Kalistratos Kabilafkas, Timoleon Kabilafkas, Chrysiliou, Panagiotis Bolvis, Jack Daniels, and Moshe Rabin. In late 2015 K. Kabilafkas, purchased a controlling block of stock in a firm named Ample-Tee, Inc. which later became Airborne Wireless. A large block of shares was also supposedly owned by 30 residences of Thailand who in fact were nominees. Defendant Daniels was installed as president as recorded in filings made with the Commission. Those filings did not mention K. Kabilafkas or the fact that he controlled the shares. Subsequently, millions of shares were distributed with the assistance of the other Defendants. During the period false financial information was distributed regarding the firm. False representations were also made to induce brokers and the transfer agent to handle and process the shares; false publicity about the company created demand; and the price rose. Eventually Defendant K. Kabilafkas dumped his shares reaping profits of about $23 million. During the period the company also raised about $22 million from other investors. Collectively, Defendants netted over $45 million. The complaint alleges violations of each subsection of Securities Act Section 17(a) and Exchange Act Sections 10(b) and 20(a). The case is pending. See Lit. Rel. No. 25043 (March 2, 2021).
You are right.. I see the bold loud print and just click on past it. It is like a kid trying to get attention all the time...
Right.. Thanks for correcting that. And still, to me at least there are too many companies trying to steer the ship. That was my point.
MelsDollars ... again you bring up good points. When Relief joined with ACER, that may have offset NeuroRx management. We are dealing with some big egos and companies trying to gain position. It would make sense that NeuroRx would not want relief to do a parallel competing trial with inhaled.
and... this may have been the trigger event that started all the division. I am just guessing here because for now, that is all we can do.
https://www.globenewswire.com/fr/news-release/2021/01/25/2163525/0/en/Relief-Therapeutics-and-Acer-Therapeutics-Sign-Option-Agreement-for-Exclusivity-to-Negotiate-a-Collaboration-and-License-Agreement-for-the-Worldwide-Development-and-Commercializati.html
Yeah MelsDollars... You are right...as a reminder... It is a proven drug no doubt. I have been wondering if they are purposely delaying things a bit, slowing it down and looking more toward the future with the inhaled version which could be tremendously faster to administer. If they withheld the data from Relief then that may have simply been a tactical move even though they probably knew it would irritate some people.. Perhaps they also do not want RELIEF to step on what they have done with the results and do not want all the details released to the World yet... again for tactical reasons.
I could be wrong.. but I am considering buying a lot more at these prices. It is only money! LOL
MelsDollars ... Good points. There is a lot more happening in the background that we don't know. It is like an outlaw gang pulling off the prefect robbery and then knocking each other off when it comes time to split the pot in an effort to increase their share of the loot! LOL But yes, with the possible merger and possible tactical positioning, we still know very little about the root cause of all this.
Thanks for posting that info...
Even if half the number of people are projected to die as mentioned in that article, it seems like such a sad and ignorant delay by the powers to be when 85% could be saved by ZYESAMI...
Rapid COVID tests about to land in Australia
By 9News Staff
7:21pm Apr 8, 2021
https://www.9news.com.au/national/new-rapid-covid-testing-machines-that-provide-a-result-in-20-seconds-will-soon-arrive-in-australia-following-approval-for-use-in-the-uk/6ca6f110-5639-46b8-8d93-c96c2ad2287c
New Covid test which gives result in 20 seconds approved for use in Scotland
https://www.edinburghlive.co.uk/news/edinburgh-news/new-covid-test-gives-result-20286483
XTEK (ASX:XTE) to exclusively distribute 20-second COVID-19 screening test
https://themarketherald.com.au/xtek-asxxte-to-exclusively-distribute-20-second-covid-19-screening-test-2021-03-31/
City of London 20 second COVID-19 screening tests to launch
29 March 2021 08:42
https://www.med-technews.com/news/Covid-19-Medtech-News/city-of-london-20-second-covid-19-screening-tests-to-launch/
It would be wonderful if all the covid infections went away...but sadly covid 19 and variants will be around and will still infect and kill people.. There still remains millions who will need help in underdeveloped countries as well... And.. The inhaled version may be very useful for other issues. Time will tell.
Ria2... Sorry.. I was not trying to criticize you at all.. I am too imperfect myself to talk about anyone else... LOL But I hear ya.. There are others .. not you who constantly complain.. and love capital letters.. I just don't understand people like that.
Well.. We all have our own thoughts on this. To me any news especially with main stream media is great! Without doubt...people with family members who are dying now will hear this and one can expect that they would be investigating options to use Aviptadil. Doctors as well may be enlightened. The data is out there on this and it is undeniable. If it were not, the FDA would be all over the report just released calling out Dr J...
People complaining about SP here are only looking at short term or they bought in way too late and have not averaged down.
Patience is a virtue.
I would think that since Fox showed it, other networks would follow in kind. All these networks try to keep up with each other. The CDC is starting to panic people about this new strain from Britain being the new dominant form and being more contagious and dangerous and deadly. Questioning the vaccines and the duration of their effectiveness or even if they are effective against these newest strains or future new strains. If we ever needed a good therapeutic we need it more now!